Filter posts

Picks and Pans – The Buy-Side View for 2012

What’s the forecast for biotech in 2012? Do investors think it is a good time …

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s …

AUTM Website Helps Commercialize University Technologies

By Robin L. Rasor, CLP, RTTP, AUTM President As president of the Association of University …

Patent Awards for Humanitarian Ventures

The USPTO recently announced the Patents for Humanity Challenge which awards patent owners and licensees …

Fireside Chat with Moncef Slaoui, GlaxoSmithKline

Moncel Slaoui, chairman of research and development (R&D) at GlaxoSmithKline (GSK), opened the 2012 BIO …

Petroleum Refiners Express Contempt for RFS

At the National Biodiesel Conference earlier this week, AFPM President Charles Drevna called the Renewable …

BIO Helps You Continuously Connect

By Rob Wright, Life Science Leader As I perused a bunch of the show agendas …

Biotech Crops Are Winning Over Farmers

Fortune magazine’s Marc Gunther wrote a blog this week about the growing adoption of  biotech …

A Very Big BTK January

We all heard reports that January was a great start to 2012 for the stock …

The BioGENEius Challenge: Prarthana Dalal

By Prarthana Dalal, 2011 International BioGENEius Challenge 1st Place Winner Project Title: Modeling of human …